Daily edition
Everything The Care Ledger published that day: 1 story, the news in brief and the figures.
A proposed rule carrying out a 2026 law would also limit how drug benefit managers are paid in Part D and end generic drug copays for the poorest enrollees in 2028.
6million
low-income enrollees whose generic drug copays would fall to $0 in 2028
Medicare proposal would cap costs for patients misled by wrong provider directories
$1.337billion
net federal cost of eliminating those copays from 2028 to 2037
Medicare proposal would cap costs for patients misled by wrong provider directories
90days
how often plans would have to verify most directory listings
Medicare proposal would cap costs for patients misled by wrong provider directories
$444million
Congressional Budget Office estimate of federal savings from the Part D PBM fee limit, 2026 to 2035
Medicare proposal would cap costs for patients misled by wrong provider directories
